-
Jun. 03, 2019
-
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests- -
May. 31, 2019
- The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
-
May. 27, 2019
- Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field
-
May. 08, 2019
- Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 (PDF：389KB)
-
May. 08, 2019
- Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2019 (PDF：59KB)
-
May. 08, 2019
- Notice of the Booking of an Extraordinary Loss (Non-Consolidated) in Relation to an Affiliated Company (PDF：27KB)
-
May. 08, 2019
- Announcement Related to Granting of Stock Options (Stock Acquisition Rights) as a Part of Compensation to Members of the Managing Board (PDF：89KB)
-
May. 08, 2019
- Announcement of Executive Change (PDF：130KB)
-
May. 08, 2019
-
Sysmex Announces New Group Mid-Term Management Plan
-Working to Enhance the Group’s Growth Potential and Reinforce the Management Base with a View to Sustainable Growth- (PDF：117KB) -
May. 08, 2019
-
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
-Strengthening Diagnostic Reagent Functions through an Integrated Structure from the Development of Substances to the Development, Production and Distribution of Bio-Diagnostic Reagents-
Topics
- May. 31, 2019
- Notice of the 52nd Ordinary General Meeting of Shareholders
- May. 08, 2019
- Posted Financial Results for the Fiscal Year Ended March 31, 2019
- Mar. 29, 2019
- Sysmex Closes 50th Annniversary Website
- Mar. 08, 2019
- Posted the 16th Technology Presentation
- Feb. 06, 2019
- Posted Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
